Press release
Nanoparticle Formulation Market to Grow at 8.9% CAGR from 2025 to 2034
Nanoparticle Formulation Market
Advances in nanotechnology, gene therapy, and precision drug delivery systems are reshaping global pharmaceutical manufacturing and driving robust growth in the nanoparticle formulation market.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/72422
Introduction
The Nanoparticle Formulation Market is at the forefront of next-generation therapeutics, propelled by breakthroughs in nanomedicine, controlled drug release, and targeted therapy delivery.
Valued at USD 10.5 billion in 2024, the market is projected to reach USD 24.8 billion by 2034, growing at a CAGR of 8.9% over the forecast period.
Rising demand for mRNA vaccines, oncology nanocarriers, and bioavailable formulations is fueling rapid adoption of nanoparticles across the pharmaceutical, biotech, and diagnostic sectors. These advances are enabling more efficient treatments with fewer side effects and better patient adherence.
Key Players in the Market
The nanoparticle formulation ecosystem includes global pharmaceutical manufacturers, CDMOs, and technology innovators specializing in nanocarrier design and manufacturing.
Leading companies include:
• Pfizer Inc.
• Moderna Therapeutics Inc.
• Lonza Group AG
• Evonik Industries AG
• Merck KGaA
• CordenPharma International GmbH
• BASF SE
• Gilead Sciences Inc.
• CureVac AG
• NanoComposix Inc.
These firms are heavily investing in lipid nanoparticle (LNP), polymeric, and inorganic nanoparticle technologies to optimize the delivery of biologics, vaccines, and precision therapies.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/72422/nanoparticle-formulation-market
Key Events in the Last Five Years
• 2020-2021: The COVID-19 pandemic accelerated global recognition of LNP-based mRNA delivery platforms, setting a new standard in vaccine technology.
• 2022: Lonza expanded its capacity for viral vector and nanoparticle formulation services to meet rising biotech demand.
• 2023: Evonik Industries launched a new Lipid Innovation Center in the U.S. to develop advanced nanoparticle excipients.
• 2024: Moderna and CordenPharma strengthened long-term collaboration for scalable LNP and nucleic acid therapeutics manufacturing.
Market Growth Rate
According to Exactitude Consultancy, the nanoparticle formulation market is set to grow at a CAGR of 8.9% from 2025 to 2034, driven by:
• Expanding use of nanocarriers in oncology and genetic medicine.
• Continuous innovations in lipid, polymeric, and hybrid nanoparticle platforms.
• Rising CDMO investments for large-scale, GMP-compliant production.
• Enhanced regulatory guidance for nanotechnology-enabled pharmaceuticals.
Market Segments and Growth Analysis
The market is segmented by formulation type, application, and region.
By Formulation Type:
• Lipid Nanoparticles (LNPs)
• Polymeric Nanoparticles
• Metallic/Inorganic Nanoparticles
• Hybrid and Composite Nanocarriers
By Application:
• Drug Delivery (Oncology, Neurology, Infectious Diseases)
• Gene and mRNA Therapy
• Vaccines and Immunotherapy
• Diagnostic Imaging and Biosensors
• Nutraceuticals and Cosmetics
By Region:
• North America: Leads due to strong pharmaceutical R&D investment and FDA nanomedicine guidelines.
• Europe: Accelerating adoption in clinical trials and imaging applications.
• Asia Pacific: Fastest-growing region, fueled by biomanufacturing expansion in China, India, and South Korea.
• Latin America & MEA: Gradual increase in R&D funding and academic research partnerships.
Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72422
Key Market Drivers
1. Growth of Precision and Targeted Medicine:
Nanoparticle systems enhance treatment accuracy and reduce off-target effects, particularly in oncology and neurology.
2. Surging mRNA and Gene Therapy Development:
Lipid nanoparticles remain essential for RNA-based vaccines and CRISPR delivery.
3. AI-Driven Nanoparticle Design:
Machine learning accelerates optimization of nanocarrier size, charge, and stability for superior efficacy.
4. Increasing CDMO Collaborations:
Pharmaceutical companies outsource nanoparticle formulation for cost-effective scale-up and compliance.
Recent Developments
• 2023: CordenPharma expanded its LNP platform capacity to support mRNA vaccine developers.
• 2024: BASF SE introduced new nanopolymer formulations improving solubility of poorly water-soluble drugs.
• 2024: Gilead Sciences initiated trials for nanoparticle-based HIV and hepatitis B therapies.
• 2024: NanoComposix launched standardized nanoparticle reference materials for analytical testing and quality control.
Expert Insight
"Nanoparticle formulation has transitioned from an emerging niche to a mainstream pharmaceutical discipline. Its application in mRNA, oncology, and precision drug delivery is redefining what's possible in modern medicine,"
- Dr. Isabella Frey, Head of Nanomedicine Research, University of Cambridge.
Conclusion
The Nanoparticle Formulation Market represents one of the fastest-evolving segments of modern drug development.
With expanding applications in gene therapy, mRNA vaccines, and targeted oncology, nanoparticle formulations are central to the next wave of pharmaceutical innovation.
As AI integration, global CDMO capacity, and nanomaterial standardization advance, the market will play a pivotal role in shaping personalized and regenerative medicine through 2034.
This report is also available in the following languages : Japanese (ナノ粒子製剤市場), Korean (나노입자 제형 시장), Chinese (纳米颗粒制剂市场), French (Marché des formulations de nanoparticules), German (Markt für Nanopartikelformulierungen), and Italian (Mercato della formulazione delle nanoparticelle), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/72422
Our More Reports:
Isovaleric Acidemia Market
https://exactitudeconsultancy.com/reports/72053/isovaleric-acidemia-market
Metachromatic Leukodystrophy Market
https://exactitudeconsultancy.com/reports/72057/metachromatic-leukodystrophy-market
Prediabetes Market
https://exactitudeconsultancy.com/reports/72063/prediabetes-market
Subarachnoid Hemorrhage Market
https://exactitudeconsultancy.com/reports/72076/subarachnoid-hemorrhage-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Nanoparticle Formulation Market to Grow at 8.9% CAGR from 2025 to 2034 here
News-ID: 4257286 • Views: …
More Releases from Exactitude Consultancy
Lymphedema Market Poised for Robust Growth Through 2034 Amid Rising Awareness an …
Pune, India - November 2025 - According to a new report by Exactitude Consultancy, the global Lymphedema Market is set to witness significant growth in the coming decade, propelled by early diagnosis initiatives, expanding therapeutic options, and increased adoption of compression and physiotherapy devices. The market's evolution reflects a strong convergence of healthcare innovation, patient education, and government support programs.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72055
Key Takeaways
• The…
Somatotropin Deficiency Market to Exhibit Steady Growth Through 2034 as Novel Th …
Market forecast shows a compound annual growth rate (CAGR) of approximately 4.4% from 2024 to 2034, driven by technological advances and expanding adult patient coverage.
Pune, India - November 2025 - Exactitude Consultancy reports that the global Somatotropin (Growth Hormone) Deficiency Market is poised for consistent expansion over the next decade. Rising prevalence of growth hormone deficiency (GHD), greater diagnostic accuracy, and innovative long-acting therapies are transforming this highly specialized endocrine…
Vitreous Enamel Panel (VE Panel) Market to Grow at 6.7% CAGR, Reaching USD 2.47 …
Snippet:
The Vitreous Enamel Panel (VE Panel) Market is gaining strong momentum as modern architects and infrastructure developers turn to durable, fire-resistant, and aesthetic wall-cladding materials. With leading manufacturers like AUE, TGP, and CELSA Group innovating in sustainable enamel coating technologies, the VE Panel industry is poised for substantial growth through 2034.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/75478
What Are Vitreous Enamel Panels (VE Panels)?
Vitreous enamel panels are metal…
Flame Retardant Resin Market to Grow at 6.3% CAGR, Reaching USD 13.8 Billion by …
Snippet:
The Flame Retardant Resin Market is expanding rapidly as global safety standards tighten across electrical, automotive, and building industries. With industry leaders such as BASF SE, Clariant AG, and Lanxess AG pioneering high-performance, eco-friendly formulations, the market is set for robust growth through 2034.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/75482
What Are Flame Retardant Resins?
Flame retardant resins are engineered polymer materials designed to resist ignition and inhibit flame…
More Releases for Nanoparticle
The Role Of Nanoparticle Analysis In Addressing The Rising Prevalence Of Cancer: …
The Nanoparticle Analysis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Nanoparticle Analysis Market?
The expansion of the nanoparticle analysis market has been swift in the previous years. Projections indicate that it will rise from $5.25 billion in 2024…
Lipid-Nanoparticle Based Genomic Medicines Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Lipid-Nanoparticle Based Genomic Medicines Market - (By Type (Liposome-based Nanoparticles, Micelle-based Nanoparticles, Lipid-Coated Nanoparticles), By Application (Cancer Treatment, Infectious Diseases, Genetic Disorders, Cardiovascular Diseases, Others), By Therapeutic Payload (mRNA-based Therapeutics, siRNA-based Therapeutics, miRNA-based Therapeutics, Other Genomic Medicines), By End-User (Hospitals, Biopharmaceutical Companies, Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the…
Nanoparticle Analysis Market Size and Forecast
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Nanoparticle Analysis Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion.
The nanoparticle analysis market encompasses a range of technologies and instruments used for the characterization and study of nanoparticles. With the increasing applications of nanoparticles…
Latest Trends In Global Nanoparticle Analyzer Market
A technique for observing and examining particles in liquids is called nanoparticle tracking analysis (NTA). Little particles (between 10 and 1000 nm) are suspended in a liquid using NTA, enabling the creation of a size distribution profile.
Nanotechnology is a vast area of study that focuses on materials and uses that take place at extremely small scales.To determine the size of individual particles and the size distribution range for a…
Cerium Oxide Nanoparticle Market 2022 | Detailed Report
This report provides an informative view about the competitive aspect of the global market. It includes detailed picture of the exhibition of a portion of the essential global players working in the Cerium Oxide Nanoparticle market. The research study also provides historical record with profits predictions and forecasts from 2022 to 2028. Also, the business manufacturing of the notable manufacturers is also emphasized with technical data in the report.
This report…
ORU Scientist Helps Develop Novel Nanoparticle Technology
Tulsa, OK – Oral Roberts University Scientist, Dr. Enrique Valderrama-Araya, who in collaboration with material scientists from Brazil, China, the UK, and the USA, has developed a novel hydrogen evolution reaction for exploring the extent of platinum nanoparticles dissolution upon the surface of carbon nanostructured electrodes.
The team’s research, recently published in Nanoscale, a high impact international journal, demonstrated how platinum nanoparticles can potentially be used to cheaply mass manufacture catalyst…
